Taysha Gene Therapies TSHA
NASDAQ TSHA
$4.74 -0.13 (-2.67%)
At close: Oct 1, 2026 · 4:00 PM EDT

Taysha Gene Therapies (TSHA) Other Operating Expenses (2022 - 2026)

Updated

Taysha Gene Therapies (TSHA) reported Other Operating Expenses of $3.43 million for Q2 2026.

Analysis

Taysha Gene Therapies (TSHA) Other Operating Expenses (2022 - 2026) Analysis & Trends

For FY2024, Taysha Gene Therapies posted Other Operating Expenses of $4.84 million, up 354.3% from FY2023.

  • By year, Other Operating Expenses came in at $1.07 million in FY2023 (-97.1%) and $36.42 million in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly Other Operating Expenses since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Taysha Gene Therapies 1.58 Bn 1.58 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.43 Mn
Sep 30, 2024 4.84 Mn
Dec 31, 2023 449,000.00
Sep 30, 2023 616,000.00
Dec 31, 2022 36.42 Mn
API Access

Taysha Gene Therapies Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=TSHA&period=max&api_key=YOUR_API_KEY